In a move to potentially improve the accessibility of rehabilitation technologies, Robotimize Group and Loutkar Robotics have signed a Letter of Intent (LOI) to explore a long-term collaboration focusing on rehabilitation robotics. The signing ceremony took place in Malaysia on November 12, 2026, with key figures Kerry Guo, Founder and CEO of Robotimize Group, and Francisco Pérez, CTO and Co-Founder of Loutkar Robotics, as signatories. This agreement marks the beginning of discussions on how the two companies can merge their complementary technologies to enhance rehabilitation solutions.
Robotimize Group is known for its integrated rehabilitation technology ecosystem and strategic partnerships, while Loutkar Robotics specializes in robotic orthoses for lower limb rehabilitation, emphasizing lightweight, modular, and accessible designs. These technologies are particularly relevant to neurorehabilitation programs aimed at helping individuals regain mobility and functional independence after conditions such as strokes.
The LOI serves as a framework for the companies to explore potential cooperation opportunities rather than confirming a formal commercial partnership or specific product launch. Robotimize’s initiatives, such as ACE™ and VivantePlexus™, support clinician-led rehabilitation and technology-enabled care pathways. A collaboration with Loutkar Robotics could enhance this approach by incorporating expertise in robotic orthoses.
Rehabilitation robotics, which includes wearable devices, movement assistance, and sensing systems, is crucial in supporting therapy and monitoring patient progress. Robotic orthoses can assist users with movement and provide clinicians with valuable information for individualized training. However, wider adoption faces challenges like affordability and ease of use. Collaborations between specialized technology developers could help address these challenges by combining their capabilities.
Kerry Guo highlighted that the LOI reflects a shared commitment to making rehabilitation robotics more accessible. Zen Koh, Scientific Advisor at Robotimize Group, also emphasized the importance of this accessibility for both clinicians and users. The proposed collaboration aims to explore how each company’s expertise can contribute to more comprehensive rehabilitation options.
This development occurs amidst ongoing advancements in rehabilitation technology across clinical and community care settings. With conditions like stroke and neurodegenerative diseases creating diverse mobility needs, a range of specialized tools is essential for clinicians. Robotimize Group and Loutkar Robotics will now investigate the potential for a mutually beneficial, long-term relationship.
About Robotimize Group
Robotimize Group is a health technology company headquartered in Singapore, specialising in intelligent rehabilitation robotics and digital neurotechnologies. Through VivantePlexus™, its integrated rehabilitation technology ecosystem, and ACE™, its strategic partnerships portfolio, Robotimize develops and distributes technologies designed to support clinician-led rehabilitation, functional training, and technology-enabled care pathways across institutional and community settings. Product availability, indications, and use are subject to applicable regulatory approvals and local clinical requirements.
For more information, visit: http://www.robotimize.tech
Jerry HONG
Robotimize Group
+60 11-1224 1674
Legal Disclaimer:
The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.
